← All stocks

BioAge Labs, Inc.

BIOA Scheduled selling only

CIK 0001709941 #3181 in the set updated 18 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$7.79M

$4.22M on a plan · $3.57M straight out of an exercise

Sold at will

$0.00

0 of 13 sales

Net

−$7.79M

$0.00 against sales at will

By person

8 insiders · 17 transactions

41.0×

Kristen Fortney holds 41.0 times base salary in stock. $24.61M of shares against $600.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Kristen Fortney last reported holding, valued at $25.19, the price Common Stock was last bought or sold at on the open market here, on 30 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fortney Kristen

Chief Executive Officer

—

$4.22M (1) scheduled

−$4.22M

976,949

2.13%

$24.61M

−19.3%

Barton Shane

Principal Accounting Officer

—

$1.58M (2) scheduled

−$1.58M

0.0000%

$0.00

—

RUBIN PAUL D

Chief Medical Officer

—

$1.46M (6) scheduled

−$1.46M

0.0000%

$0.00

—

GOLDSTEIN DOV A MD

Chief Financial Officer

—

$531.83K (4) scheduled

−$531.83K

36,575

0.0797%

$921.21K

+63.2%

ENRIGHT PATRICK G

Director

—

1,710,589

3.73%

$43.08M

—

Cormorant Asset Management, LP entity

Former 10% Owner

—

1,629,529

3.55%

$41.04M

—

Pande Vijay Satyanand

Director

—

1,119,195

2.44%

$28.19M

—

HEALY JAMES

Director

—

26,497

0.0577%

$667.37K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Fortney Kristen

13 Jan 2026

Chief Executive Officer

Sold on a plan

233,107

$18.12

$4.22M

Show all 17 transactions →

What was left out

Form 4 filings counted 24

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 12

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 219,117

History held since 27 Sep 2024